Treatment of depressive disorders in epilepsy patients

Epilepsy and Behavior

Volumn 3, Issue 5 SUPPL. 1, 2002, Pages 2-9

  Gilliam, Frank ^a   Kanner, Andres M ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

Depression; Epilepsy; Health outcomes; Mood; Quality of life; Seizures

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; CYTOCHROME P450 INHIBITOR; ETIRACETAM; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; LAMOTRIGINE; MAPROTILINE; MIANSERIN; MONOAMINE OXIDASE INHIBITOR; OXCARBAZEPINE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PRIMIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIAGABINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN;

BRAIN DYSFUNCTION; CARDIOTOXICITY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDICATION; DRUG METABOLISM; ELECTROCONVULSIVE THERAPY; EPIDEMIOLOGICAL DATA; EPILEPSY; FOOD DRUG INTERACTION; HEALTH STATUS; HUMAN; IMAGING SYSTEM; MEDICAL INSTRUMENTATION; MENTAL DISEASE; PATHOGENESIS; PREVALENCE; PSYCHOTHERAPY; REVIEW; SCREENING TEST; SOCIAL DISABILITY; SOCIAL PSYCHOLOGY; TREATMENT PLANNING; VOCATION;

EID: 0036816667     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1525-5069(02)00503-0     Document Type: Review

References (62)

1. Lewis AJ. Melancholia: a historical review. J Ment Sci 1934;80:1-42.
2. Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999;40(Suppl 10):S21-47.
3. Indaco A, Carrieri PB, Nappi C, Gentile S, Striano S. Interictal depression in epilepsy. Epilepsy Res 1992;12:45-50.
4. Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a UK Community study. Epilepsia 1996;37:148-61.
5. Baker GA, Jacoby A, Chadwick DW. The associations of psychopathology in epilepsy: a community study. Epilepsy Res 1996;25:29-39.
6. Edeh J, Toone B. Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice. Br J Psychiatry 1987;151:95-101.
7. Mendez MF, Cummings JL, Benson DF. Depression in epilepsy. Significance and phenomenology. Arch Neurol 1986;43:766-70.
8. Robertson MM, Trimble MR. Depressive illness in patients with epilepsy: a review. Epilepsia 1983;24(suppl 2):S109-16.
9. O'Donoghue MF, Goodridge DM, Redhead K, Sander JW, Duncan JS. Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract 1999;49:211-4.
10. Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997;38:233-6.
11. Robertson MM. Suicide, parasuicide, and epilepsy. In: Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven; 1997.
12. Rafnsson V, Olafsson E, Hauser WA, Gudmundsson G. Cause-specific mortality in adults with unprovoked seizures. A population-based incidence cohort study. Neuroepidemiology 2001;20:232-6.
13. Nilsson L, Tomson T, Farahmand BY, Diwand V, Persson PG. Cause-specific mortality in epilepsy: a cohort study of more than 9000 patients once hospitalized for epilepsy. Epilepsia 1997;38:1062-8.
14. Perrine K, Hermann BP, Meador KJ, et al. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995;52:997-1003.
15. Lehrner J, Kalchmayr R, Serles W, et al. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 1999;8:88-92.
16. Gilliam F, Kuzniecky R, Meador K, et al. Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology 1999;53:687-94.
17. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;58(8 Suppl 5):S9-20.
18. Quiske A, Helmstaedter C, Lux S, Elger CE. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res 2000;39:121-5.
19. Schmitz EB, Moriarty J, Costa DC, Ring HA, Ell PJ, Trimble MR. Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy. J Neurol Neurosurg Psychiatry 1997;62:458-63.
20. Gilliam F, Maton B, Martin RC, et al. Extent of 1H spectroscopy abnormalities independently predicts mood status and quality of life in temporal lobe epilepsy [abstract]. Epilepsia 2000;41(Suppl):54.
21. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996;93:3908-13.
22. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999;19:5034-43.
23. Drevets WC, Price JL, Bardgett ME, Riech T, Todd RD, Raichle ME. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 2002;71:431-47.
24. Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001;11:240-9.
25. Brody AL, Saxena S, Stoessel P, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001;58:631-40.
26. Brody AL, Saxena S, Mandelkern MA, Fairbanks LA, Ho ML, Baxter LR. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry 2001;50:171-8.
27. Kanner AM, Barry JJ. Is the psychopathology of epilepsy different from that of nonepileptic patients? Epilepsy Behav 2001; 2:170-86.
28. Mendez MF, Doss RC, Taylor JL, Salguero P. Depression in epilepsy. Relationship to seizures and anticonvulsant therapy. J Nerv Ment Dis 1993;181:444-7.
29. Wiegartz P, Seidenberg M, Woodard A, Gidal B, Hermann B. Comorbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. Neurology 1999;53(5 suppl 2):S3-8.
30. Blumer D. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. J Clin Psychiatry 1997;58: 3-11.
31. Kanner AM, Kozak AM, Frey M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav 2000;1:100-5.
32. Williams D. The structure of emotions reflected in epileptic experiences. Brain 1956;79:29-67.
33. Weil A. Depressive reactions associated with temporal lobe uncinate seizures. J Nerv Ment Dis 1955;121:505-10.
34. Weil A. Ictal emotions occurring in temporal lobe dysfunction. Arch Neurol 1959;1:87-97.
35. Mulder D, Daly D. Psychiatric symptoms associated with lesions in the temporal lobe. JAMA 1952;150:173-6.
36. Kanner AM, Palac S. Depression in epilepsy: a common but often unrecognized comorbid malady. Epilepsy Behav 2000;1:37-51.
37. Hermann BP, Seidenberg M, Bell B. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 2000;41(Suppl 2):S31-41.
38. Bromfield EB, Altshuler L, Leiderman DB, et al. Cerebral metabolism and depression in patients with complex partial seizures. Arch Neurol 1992;49:617-23.
39. Blanchet P, Frommer GP. Mood change preceding epileptic seizures. J Nerv Ment Dis 1986;174:471-6.
40. Kanner AM, Soto A, Kanner-Gross HR. There is more to epilepsy than seizures: a reassessment of the postictal period. Neurology 2000;54(Suppl 3):A352.
41. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;136: 765-76.
42. Karzmark P, Zeifert P, Barry J. Measurement of depression in epilepsy. Epilepsy Behav 2001;2:124-8.
43. Schoenbaum M, Unutzer J, Sherbourne C, et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA 2001;286:1325-30.
44. Robertson MM, Trimble MR. The treatment of depression in patients with epilepsy. A double-blind trial. J Affect Disord 1985; 9:127-36.
45. Ketter TA, Malow BA, Flamini R, White SR, Post RM, Theodore WH. Anticonvulsant withdrawal-emergent psychopathology. Neurology 1994;44:55-61.
46. Preskorn SH, Fast GA. Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry 1992;53:160-2.
47. Curran S, de Pauw K. Selecting an antidepressant for use in a patient with epilepsy. Safety considerations. Drug Saf 1998;18: 125-33.
48. Blumer D, Montouris G, Hermann B. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J Neuropsychiatry Clin Neurosci 1995;7:445-56.
49. Swinkels JA, de Jonghe F. Safety of antidepressants. Int Clin Psychopharmacol 1995;9(Suppl 4):19-25.
50. Pisani F, Spina E, Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 1999;40(Suppl 10):S48-56.
51. Grimsley SR, Jann MW, Carter JG, D'Mello AP, D'Souza MJ. Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther 1991;50:10-5.
52. Pearson HJ. Interaction of fluoxetine with carbamazepine. J Clin Psychiatry 1990;51:126.
53. DeVane CL. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol 1999;19:443-66.
54. Blumer D, Davies K, Alexander A, Morgan S. Major psychiatric disorders subsequent to treating epilepsy by vagus nerve stimulation. Epilepsy Behav 2001;2:466-72.
55. Dunner DL. Optimizing lithium treatment. J Clin Psychiatry 2000;61(Suppl 9):76-81.
56. Grignon S, Bruguerolle B. Cerebellar lithium toxicity: a review of recent literature and tentative pathophysiology. Therapie 1996; 51:101-6.
57. Bell AJ, Cole A, Eccleston D, Ferrier IN. Lithium neurotoxicity at normal therapeutic levels. Br J Psychiatry 1993;162:689-92.
58. Weinstein S. The anticonvulsant effect of electrical fields. Curr Neurol Neurosci Rep 2001;1:155-61.
59. Krahn LE, Rummans TA, Peterson GC, Cascino GD, Sharbrough FW. Electroconvulsive therapy for depression after temporal lobectomy for epilepsy. Convuls Ther 1993;9:217-9.
60. Griesemer DA, Kellner CH, Beale MD, Smith GM. Electroconvulsive therapy for treatment of intractable seizures. Initial findings in two children. Neurology 1997;49:1389-92.
61. Gillham RA. Refractory epilepsy: an evaluation of psychological methods in outpatient management. Epilepsia 1990;31:427-32.
62. Mulrow CD, Williams Jr JW, Gerety MB, Ramirez G, Montiel OM, Kerber C. Case-finding instruments for depression in primary care settings. Ann Intern Med 1995;122:913-21.